FDA approves Syngenta’s new corn seed for bulk trial; first seed to contain the vital corn amylase enzyme
In Washington, the FDA approved bulk trials of a new corn seed from Syngenta which contains the corn amylase enzyme, after positive results from pilot trials. The Anglo-Swiss group company said that it has developed a means of growing the enzyme directly in the corn seeds, removing the need to ship enzymes to ethanol plants and introduce them into the conversion process. The company says its expects to have the seed ready for the 2009 growing season.
Enzymes have been the subject of intense interest in the past year, particularly for cellulosic ethanol. Shell has purchased an undisclosed stake in stake in Codexis, a cellulosic ethanol enzymes developer. VeraSun took a stake in the Q Microbe, also related to cellulosic ethanol development.
Free Subscription to the Daily Biofuels Digest e-newsletter
Subscribe FREE to the world's most-widely read biofuels daily. Enter your email in the box below,
Related Stories
Hot Topics
The Hottest 50 Companies in Bioenergy
Latest algae-to-energy news
Latest jatropha news
Latest Waste-to-energy news
Entry Information
Filed Under: Producer News • Research
Trackbacks: 1 | Trackback URL
- From Earth2Tech » Blog Archive » GM Ethanol: FDA OKs Enzyme-Producing Corn Seed Testing on Nov 13, 2007
Post a Comment | Trackback URL
You must be logged in to post a comment.


